Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 7/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6565624 | 0.86 | L3MBTL1 (0.71) | L3MBTL1HPGDTSHRMAPK1RAB9A | |
| SCHEMBL6564387 | 0.86 | RAB9A (0.67) | L3MBTL1HPGDTSHRMAPK1RAB9A | |
| SCHEMBL6565574 | 0.85 | L3MBTL1 (0.59) | L3MBTL1HPGDTSHRMAPK1RAB9A | |
| SCHEMBL6565588 | 0.84 | L3MBTL1 (0.58) | L3MBTL1HPGDTSHRMAPK1RAB9A | |
| SCHEMBL6564420 | 0.83 | L3MBTL1 (0.57) | L3MBTL1HPGDTSHRMAPK1RAB9A | |
| SCHEMBL6566385 | 0.82 | L3MBTL1 (0.56) | L3MBTL1HPGDTSHRMAPK1RAB9A | |
| SCHEMBL6564398 | 0.81 | ALDH1A1 (0.59) | L3MBTL1HPGDTSHRMAPK1RAB9A | |
| SCHEMBL1470962 | 0.79 | RAB9A (0.57) | L3MBTL1HPGDTSHRMAPK1RAB9A | |
| SCHEMBL2206387 | 0.72 | RAB9A (0.70) | L3MBTL1HPGDTSHRMAPK1RAB9A | |
| SCHEMBL12781082 | 0.72 | TSHR (0.56) | L3MBTL1HPGDTSHRMAPK1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1135360-B1 | NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA | PF MEDICAMENT (FR) | 2004-03-31 | — | — | EP | disclosed |
| US-6350913-B1 | AROMATIC AMINE COMPOUNDS | PIERRE FABRE MEDICAMENT (FR) | 2002-02-26 | — | — | US | disclosed |
| EP-1135360-A1 | NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA | PIERRE FABRE MEDICAMENT (FR) | 2001-09-26 | — | — | EP | disclosed |
| WO-2000032557-A1 | NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA | PIERRE FABRE MEDICAMENT (FR) | 2000-06-08 | — | — | WO | disclosed |